Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Second-generation sulphonylurea (Gliclazide-based)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Type-2 diabetes mellitus
- Adjunct to metformin
- Diabetic patients with vascular risk (gliclazide's antioxidant benefit)
Mechanism of Action
Gliclazide is a second-generation sulphonylurea that stimulates pancreatic beta-cell insulin secretion by closing ATP-sensitive K+ channels (SUR1). It also has antioxidant and antiplatelet effects via free-radical scavenging and reduced platelet aggregation — providing additional benefit in diabetic vascular complications.
Dosage & Administration
- Adults: 1 tablet once daily before breakfast (or as advised)
- Titrate based on glycaemic response
- Maximum 320 mg/day total gliclazide
- MR tablets: swallow whole, do not crush
Side Effects
- Hypoglycaemia
- Weight gain (mild)
- GI upset
- Skin reactions (rare)
- Cholestatic jaundice (rare)
Contraindications
- Type-1 diabetes
- Diabetic ketoacidosis
- Severe hepatic/renal impairment
- Pregnancy and breastfeeding
- Sulphonamide hypersensitivity
Storage
Store below 25°C.
PCD Pharma Franchise for Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 15 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet?
Available pack sizes include: 10 x 15 (Blister).
What is the MRP / trade price for Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet?
MRPs range from ₹2550 to ₹2550 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release Tab) Tablet?